Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Methicillin-Resistant Staphylococcus aureus | 55 | 2022 | 705 | 10.400 |
Why?
|
Cross Infection | 61 | 2022 | 1425 | 9.870 |
Why?
|
Staphylococcal Infections | 59 | 2019 | 1393 | 8.930 |
Why?
|
Carrier State | 43 | 2020 | 529 | 6.460 |
Why?
|
Infection Control | 36 | 2020 | 982 | 5.090 |
Why?
|
Chlorhexidine | 12 | 2019 | 159 | 3.640 |
Why?
|
California | 43 | 2019 | 1436 | 3.240 |
Why?
|
Nursing Homes | 18 | 2020 | 1084 | 2.970 |
Why?
|
Disinfection | 9 | 2019 | 207 | 2.850 |
Why?
|
Hospitals | 29 | 2022 | 3887 | 2.830 |
Why?
|
Mupirocin | 8 | 2019 | 55 | 2.190 |
Why?
|
Surgical Wound Infection | 16 | 2022 | 1544 | 2.020 |
Why?
|
Methicillin Resistance | 12 | 2011 | 198 | 1.970 |
Why?
|
Bacteremia | 14 | 2022 | 988 | 1.910 |
Why?
|
Enterobacteriaceae Infections | 7 | 2020 | 190 | 1.910 |
Why?
|
Intensive Care Units | 24 | 2019 | 3799 | 1.830 |
Why?
|
Catheter-Related Infections | 7 | 2022 | 279 | 1.820 |
Why?
|
Drug Resistance, Multiple, Bacterial | 11 | 2020 | 592 | 1.800 |
Why?
|
Enterococcus | 11 | 2013 | 158 | 1.730 |
Why?
|
Pneumococcal Infections | 15 | 2017 | 527 | 1.700 |
Why?
|
Disinfectants | 5 | 2019 | 131 | 1.530 |
Why?
|
Vancomycin Resistance | 10 | 2013 | 125 | 1.470 |
Why?
|
Staphylococcus aureus | 15 | 2019 | 1424 | 1.460 |
Why?
|
Drug Resistance, Bacterial | 11 | 2016 | 1065 | 1.360 |
Why?
|
Disease Outbreaks | 12 | 2020 | 1760 | 1.290 |
Why?
|
Streptococcus pneumoniae | 14 | 2017 | 761 | 1.240 |
Why?
|
Anti-Infective Agents, Local | 5 | 2019 | 246 | 1.230 |
Why?
|
Baths | 4 | 2019 | 52 | 1.220 |
Why?
|
Pneumococcal Vaccines | 11 | 2017 | 413 | 1.070 |
Why?
|
Enterocolitis, Pseudomembranous | 4 | 2015 | 264 | 1.020 |
Why?
|
Gram-Positive Bacterial Infections | 7 | 2013 | 339 | 1.020 |
Why?
|
Anti-Bacterial Agents | 24 | 2019 | 7476 | 0.960 |
Why?
|
Colon | 5 | 2022 | 1796 | 0.920 |
Why?
|
Carbapenems | 4 | 2017 | 125 | 0.890 |
Why?
|
Enterobacteriaceae | 4 | 2017 | 161 | 0.840 |
Why?
|
Population Surveillance | 15 | 2016 | 2595 | 0.820 |
Why?
|
Sepsis | 6 | 2016 | 2603 | 0.810 |
Why?
|
Urinary Tract Infections | 4 | 2022 | 804 | 0.800 |
Why?
|
Patients' Rooms | 5 | 2015 | 63 | 0.790 |
Why?
|
Community-Acquired Infections | 6 | 2013 | 470 | 0.770 |
Why?
|
Catheterization, Central Venous | 3 | 2015 | 538 | 0.760 |
Why?
|
Housekeeping, Hospital | 2 | 2013 | 17 | 0.730 |
Why?
|
Long-Term Care | 4 | 2019 | 630 | 0.720 |
Why?
|
Influenza, Human | 3 | 2019 | 1539 | 0.690 |
Why?
|
Patient Transfer | 6 | 2013 | 789 | 0.670 |
Why?
|
Hospitalization | 11 | 2019 | 10803 | 0.660 |
Why?
|
Digestive System Surgical Procedures | 4 | 2021 | 581 | 0.640 |
Why?
|
Disease Notification | 4 | 2013 | 95 | 0.640 |
Why?
|
Patient Readmission | 6 | 2015 | 3284 | 0.620 |
Why?
|
Nasal Cavity | 8 | 2014 | 309 | 0.610 |
Why?
|
Guideline Adherence | 5 | 2017 | 2235 | 0.600 |
Why?
|
Patient Isolation | 4 | 2015 | 101 | 0.590 |
Why?
|
Molecular Typing | 3 | 2013 | 115 | 0.580 |
Why?
|
Computer Simulation | 6 | 2016 | 6252 | 0.580 |
Why?
|
Prevalence | 21 | 2020 | 15832 | 0.570 |
Why?
|
Quality Indicators, Health Care | 4 | 2017 | 1805 | 0.510 |
Why?
|
Hysterectomy | 2 | 2018 | 865 | 0.490 |
Why?
|
Urinary Catheterization | 1 | 2016 | 195 | 0.490 |
Why?
|
Humans | 144 | 2022 | 765823 | 0.490 |
Why?
|
Vaccines, Conjugate | 4 | 2010 | 334 | 0.480 |
Why?
|
Diagnostic Tests, Routine | 4 | 2018 | 788 | 0.480 |
Why?
|
Environmental Microbiology | 2 | 2012 | 47 | 0.470 |
Why?
|
International Classification of Diseases | 5 | 2016 | 933 | 0.470 |
Why?
|
Personnel, Hospital | 2 | 2014 | 285 | 0.470 |
Why?
|
Pneumonia, Staphylococcal | 1 | 2014 | 38 | 0.460 |
Why?
|
Patient Discharge | 9 | 2015 | 3461 | 0.450 |
Why?
|
Acinetobacter Infections | 1 | 2014 | 74 | 0.450 |
Why?
|
Influenza Vaccines | 2 | 2019 | 780 | 0.450 |
Why?
|
Health Facilities | 3 | 2016 | 577 | 0.450 |
Why?
|
Contact Tracing | 2 | 2020 | 274 | 0.440 |
Why?
|
Patient Admission | 5 | 2015 | 1364 | 0.430 |
Why?
|
Cluster Analysis | 13 | 2020 | 2719 | 0.430 |
Why?
|
Occupational Health Services | 1 | 2014 | 150 | 0.430 |
Why?
|
Interinstitutional Relations | 2 | 2013 | 234 | 0.430 |
Why?
|
Meningococcal Vaccines | 4 | 2007 | 96 | 0.420 |
Why?
|
Computer Systems | 1 | 2014 | 466 | 0.420 |
Why?
|
Hospital Shared Services | 1 | 2012 | 16 | 0.420 |
Why?
|
Candidiasis | 1 | 2015 | 372 | 0.410 |
Why?
|
Sentinel Surveillance | 4 | 2015 | 292 | 0.410 |
Why?
|
Health Policy | 3 | 2016 | 2699 | 0.410 |
Why?
|
Retrospective Studies | 38 | 2022 | 81505 | 0.410 |
Why?
|
Disease Transmission, Infectious | 7 | 2019 | 560 | 0.410 |
Why?
|
Vaccination | 4 | 2014 | 3425 | 0.400 |
Why?
|
Medicare | 7 | 2021 | 6816 | 0.390 |
Why?
|
Microbial Sensitivity Tests | 8 | 2016 | 1971 | 0.390 |
Why?
|
Vancomycin | 3 | 2013 | 504 | 0.390 |
Why?
|
Health Facility Administration | 1 | 2011 | 29 | 0.390 |
Why?
|
Nasopharynx | 6 | 2012 | 419 | 0.380 |
Why?
|
Aged | 43 | 2021 | 171178 | 0.370 |
Why?
|
Aged, 80 and over | 26 | 2017 | 59506 | 0.370 |
Why?
|
Hospitals, County | 1 | 2011 | 18 | 0.370 |
Why?
|
Clinical Coding | 1 | 2012 | 188 | 0.370 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2012 | 133 | 0.360 |
Why?
|
Middle Aged | 44 | 2019 | 223016 | 0.360 |
Why?
|
Laparoscopy | 1 | 2022 | 2037 | 0.350 |
Why?
|
Serotyping | 9 | 2012 | 330 | 0.350 |
Why?
|
Electronic Health Records | 5 | 2017 | 4864 | 0.350 |
Why?
|
Arthroplasty, Replacement, Hip | 4 | 2017 | 1415 | 0.330 |
Why?
|
Male | 62 | 2019 | 363740 | 0.330 |
Why?
|
Clostridium Infections | 2 | 2018 | 563 | 0.320 |
Why?
|
Cost Savings | 1 | 2014 | 903 | 0.320 |
Why?
|
Epidemiologic Methods | 2 | 2011 | 1325 | 0.320 |
Why?
|
Cohort Studies | 20 | 2018 | 41643 | 0.310 |
Why?
|
Female | 64 | 2019 | 396050 | 0.310 |
Why?
|
Comparative Effectiveness Research | 2 | 2013 | 713 | 0.310 |
Why?
|
Coronary Artery Bypass | 3 | 2017 | 2188 | 0.310 |
Why?
|
Health Care Surveys | 3 | 2012 | 2424 | 0.310 |
Why?
|
Administration, Intranasal | 3 | 2019 | 482 | 0.310 |
Why?
|
beta-Lactam Resistance | 4 | 2017 | 79 | 0.310 |
Why?
|
Mandatory Programs | 3 | 2014 | 86 | 0.300 |
Why?
|
Child Day Care Centers | 2 | 2009 | 122 | 0.300 |
Why?
|
Documentation | 1 | 2014 | 915 | 0.290 |
Why?
|
Models, Economic | 2 | 2015 | 716 | 0.290 |
Why?
|
Organizational Policy | 3 | 2015 | 434 | 0.290 |
Why?
|
Adult | 36 | 2021 | 223055 | 0.280 |
Why?
|
Health Services | 1 | 2012 | 756 | 0.270 |
Why?
|
Methicillin | 1 | 2006 | 61 | 0.270 |
Why?
|
Universal Precautions | 1 | 2006 | 34 | 0.270 |
Why?
|
Length of Stay | 7 | 2015 | 6485 | 0.260 |
Why?
|
Hospital Costs | 4 | 2015 | 957 | 0.250 |
Why?
|
United States | 28 | 2021 | 72896 | 0.240 |
Why?
|
Academic Medical Centers | 7 | 2018 | 2780 | 0.230 |
Why?
|
Child, Preschool | 24 | 2017 | 42478 | 0.230 |
Why?
|
Software | 2 | 2010 | 4458 | 0.230 |
Why?
|
Inpatients | 2 | 2013 | 2564 | 0.230 |
Why?
|
Preventive Health Services | 1 | 2009 | 570 | 0.230 |
Why?
|
Comorbidity | 5 | 2019 | 10570 | 0.220 |
Why?
|
Insurance Claim Review | 4 | 2013 | 744 | 0.220 |
Why?
|
Delivery of Health Care | 5 | 2022 | 5368 | 0.220 |
Why?
|
Adolescent | 20 | 2017 | 88794 | 0.220 |
Why?
|
Health Education | 2 | 2008 | 1060 | 0.220 |
Why?
|
Massachusetts | 15 | 2017 | 8875 | 0.220 |
Why?
|
Arthroplasty, Replacement, Knee | 2 | 2013 | 1379 | 0.210 |
Why?
|
Poverty | 1 | 2015 | 2714 | 0.210 |
Why?
|
Incidence | 15 | 2016 | 21501 | 0.210 |
Why?
|
Diagnosis-Related Groups | 2 | 2015 | 445 | 0.210 |
Why?
|
Hospital Bed Capacity | 2 | 2015 | 200 | 0.210 |
Why?
|
Gram-Negative Bacteria | 3 | 2012 | 275 | 0.210 |
Why?
|
Genetic Variation | 4 | 2017 | 6607 | 0.210 |
Why?
|
Health Personnel | 3 | 2016 | 3386 | 0.210 |
Why?
|
Respiratory Tract Infections | 2 | 2008 | 1008 | 0.200 |
Why?
|
Polymerase Chain Reaction | 4 | 2016 | 6061 | 0.200 |
Why?
|
Young Adult | 14 | 2017 | 59849 | 0.200 |
Why?
|
Risk Factors | 16 | 2018 | 74853 | 0.200 |
Why?
|
Bacterial Infections | 4 | 2015 | 1387 | 0.200 |
Why?
|
Nose | 4 | 2015 | 518 | 0.200 |
Why?
|
Infant | 18 | 2017 | 36375 | 0.190 |
Why?
|
Insurance, Health | 4 | 2015 | 2521 | 0.190 |
Why?
|
Health Care Costs | 2 | 2012 | 3240 | 0.190 |
Why?
|
Penicillin Resistance | 3 | 2009 | 77 | 0.190 |
Why?
|
Gram-Positive Bacteria | 1 | 2002 | 180 | 0.180 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 2 | 2012 | 142 | 0.180 |
Why?
|
Child | 25 | 2017 | 80509 | 0.180 |
Why?
|
Multivariate Analysis | 7 | 2013 | 12056 | 0.180 |
Why?
|
Pneumonia, Ventilator-Associated | 2 | 2022 | 279 | 0.180 |
Why?
|
Molecular Epidemiology | 2 | 2013 | 472 | 0.170 |
Why?
|
Medical Audit | 2 | 2012 | 454 | 0.170 |
Why?
|
beta-Lactamases | 3 | 2017 | 308 | 0.170 |
Why?
|
Models, Theoretical | 3 | 2016 | 3563 | 0.160 |
Why?
|
Prospective Studies | 10 | 2017 | 54798 | 0.160 |
Why?
|
Hygiene | 1 | 2019 | 95 | 0.150 |
Why?
|
Risk | 4 | 2011 | 9600 | 0.150 |
Why?
|
Time Factors | 8 | 2017 | 40109 | 0.140 |
Why?
|
Attitude of Health Personnel | 1 | 2011 | 3925 | 0.140 |
Why?
|
R Factors | 1 | 2017 | 35 | 0.140 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7416 | 0.140 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 1998 | 132 | 0.140 |
Why?
|
Odds Ratio | 4 | 2015 | 9653 | 0.140 |
Why?
|
Communicable Disease Control | 2 | 2016 | 856 | 0.130 |
Why?
|
Hospitals, Teaching | 2 | 2015 | 1157 | 0.130 |
Why?
|
Drug Utilization | 4 | 2012 | 1187 | 0.130 |
Why?
|
Hospitals, Community | 2 | 2016 | 363 | 0.130 |
Why?
|
Sequence Analysis, DNA | 3 | 2016 | 4772 | 0.130 |
Why?
|
Beds | 1 | 2016 | 48 | 0.130 |
Why?
|
Mass Screening | 4 | 2015 | 5445 | 0.130 |
Why?
|
Linear Models | 3 | 2016 | 5873 | 0.130 |
Why?
|
Pneumonia | 2 | 2008 | 2156 | 0.120 |
Why?
|
Clostridium | 1 | 2015 | 100 | 0.120 |
Why?
|
Bacteriuria | 1 | 2015 | 102 | 0.120 |
Why?
|
Boston | 5 | 2017 | 9336 | 0.120 |
Why?
|
Time Management | 1 | 2015 | 53 | 0.120 |
Why?
|
Forms and Records Control | 1 | 2015 | 158 | 0.120 |
Why?
|
Acinetobacter | 1 | 2014 | 39 | 0.120 |
Why?
|
Candida | 1 | 2015 | 174 | 0.120 |
Why?
|
Stochastic Processes | 1 | 2016 | 358 | 0.120 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1998 | 663 | 0.120 |
Why?
|
Residence Characteristics | 1 | 2004 | 2115 | 0.110 |
Why?
|
Staphylococcal Protein A | 1 | 2013 | 39 | 0.110 |
Why?
|
Interferon-alpha | 1 | 1998 | 910 | 0.110 |
Why?
|
Arthroplasty, Replacement | 1 | 2017 | 314 | 0.110 |
Why?
|
Klebsiella pneumoniae | 1 | 2015 | 253 | 0.110 |
Why?
|
Measles | 1 | 2015 | 180 | 0.110 |
Why?
|
Immunization | 1 | 2017 | 1218 | 0.110 |
Why?
|
Health Facility Size | 1 | 2013 | 59 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 10383 | 0.100 |
Why?
|
Parents | 1 | 2007 | 3590 | 0.100 |
Why?
|
DNA Transposable Elements | 1 | 2017 | 765 | 0.100 |
Why?
|
Public Health | 2 | 2019 | 2678 | 0.100 |
Why?
|
Electronic Mail | 1 | 2014 | 215 | 0.100 |
Why?
|
Evidence-Based Practice | 1 | 2017 | 499 | 0.100 |
Why?
|
Genes, Bacterial | 1 | 2016 | 1076 | 0.100 |
Why?
|
Mandatory Reporting | 1 | 2013 | 123 | 0.100 |
Why?
|
Escherichia coli Infections | 1 | 2016 | 519 | 0.100 |
Why?
|
Gases | 1 | 2013 | 206 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2007 | 4056 | 0.100 |
Why?
|
Otitis Media | 2 | 2012 | 287 | 0.100 |
Why?
|
Age Distribution | 2 | 2012 | 2865 | 0.100 |
Why?
|
Algorithms | 3 | 2016 | 14062 | 0.100 |
Why?
|
Selection, Genetic | 1 | 2016 | 878 | 0.100 |
Why?
|
Anti-Infective Agents | 2 | 2016 | 986 | 0.090 |
Why?
|
Reminder Systems | 1 | 2014 | 388 | 0.090 |
Why?
|
Logistic Models | 5 | 2017 | 13266 | 0.090 |
Why?
|
Skilled Nursing Facilities | 1 | 2015 | 408 | 0.090 |
Why?
|
Insurance Claim Reporting | 1 | 2011 | 166 | 0.090 |
Why?
|
Opsonin Proteins | 1 | 2010 | 138 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2000 | 2061 | 0.090 |
Why?
|
Nasal Mucosa | 1 | 2013 | 416 | 0.090 |
Why?
|
Quality Control | 1 | 2013 | 835 | 0.090 |
Why?
|
Gastroenteritis | 1 | 2012 | 231 | 0.090 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2015 | 453 | 0.090 |
Why?
|
Fimbriae Proteins | 1 | 2010 | 133 | 0.080 |
Why?
|
Sex Factors | 3 | 2015 | 10607 | 0.080 |
Why?
|
Benchmarking | 2 | 2014 | 1054 | 0.080 |
Why?
|
Genotype | 3 | 2013 | 13023 | 0.080 |
Why?
|
Forecasting | 2 | 2016 | 2938 | 0.080 |
Why?
|
Research Design | 2 | 2017 | 6207 | 0.080 |
Why?
|
Hydrogen Peroxide | 1 | 2013 | 742 | 0.080 |
Why?
|
Feedback | 1 | 2013 | 796 | 0.080 |
Why?
|
Information Dissemination | 1 | 2017 | 1140 | 0.080 |
Why?
|
Cross-Sectional Studies | 5 | 2016 | 26276 | 0.080 |
Why?
|
Immunization Programs | 1 | 2011 | 267 | 0.080 |
Why?
|
Models, Biological | 1 | 2005 | 9441 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2331 | 0.080 |
Why?
|
Checklist | 1 | 2015 | 837 | 0.080 |
Why?
|
Evaluation Studies as Topic | 1 | 2011 | 1606 | 0.080 |
Why?
|
Vascular Surgical Procedures | 2 | 2014 | 1514 | 0.080 |
Why?
|
Ultraviolet Rays | 1 | 2013 | 1099 | 0.070 |
Why?
|
Policy | 1 | 2011 | 512 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39226 | 0.070 |
Why?
|
Renal Insufficiency | 1 | 2013 | 808 | 0.070 |
Why?
|
Thyrotropin-Releasing Hormone | 2 | 1998 | 139 | 0.070 |
Why?
|
Occupational Diseases | 1 | 2015 | 1456 | 0.070 |
Why?
|
Genetics, Population | 1 | 2012 | 943 | 0.070 |
Why?
|
Membrane Transport Proteins | 1 | 2012 | 1029 | 0.070 |
Why?
|
Communicable Diseases | 1 | 2015 | 874 | 0.070 |
Why?
|
Socioeconomic Factors | 2 | 2015 | 7840 | 0.070 |
Why?
|
Age Factors | 3 | 2013 | 18380 | 0.070 |
Why?
|
Environmental Monitoring | 1 | 2013 | 1470 | 0.070 |
Why?
|
Guidelines as Topic | 1 | 2013 | 1393 | 0.070 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2008 | 239 | 0.070 |
Why?
|
Soft Tissue Infections | 1 | 2008 | 166 | 0.070 |
Why?
|
Phylogeny | 2 | 2016 | 2835 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2013 | 22227 | 0.060 |
Why?
|
Drug Resistance, Microbial | 1 | 2008 | 833 | 0.060 |
Why?
|
Biomedical Research | 2 | 2017 | 3457 | 0.060 |
Why?
|
Risk Assessment | 6 | 2014 | 24278 | 0.060 |
Why?
|
Antibodies, Bacterial | 1 | 2010 | 1473 | 0.060 |
Why?
|
Family Health | 1 | 2009 | 1253 | 0.060 |
Why?
|
Bacteria | 1 | 2015 | 2209 | 0.060 |
Why?
|
Escherichia coli | 1 | 2016 | 4211 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2000 | 4558 | 0.060 |
Why?
|
Monte Carlo Method | 1 | 2009 | 1238 | 0.060 |
Why?
|
Macrolides | 1 | 2004 | 204 | 0.050 |
Why?
|
Bacterial Proteins | 2 | 2017 | 3832 | 0.050 |
Why?
|
Data Collection | 1 | 2012 | 3317 | 0.050 |
Why?
|
Lung Diseases | 1 | 2013 | 1939 | 0.050 |
Why?
|
Oropharynx | 2 | 2015 | 139 | 0.050 |
Why?
|
Outpatients | 1 | 2011 | 1591 | 0.050 |
Why?
|
Protein Precursors | 2 | 1998 | 1133 | 0.050 |
Why?
|
Program Evaluation | 2 | 2010 | 2501 | 0.050 |
Why?
|
HIV-1 | 1 | 2000 | 6943 | 0.050 |
Why?
|
Critical Care | 1 | 2015 | 2708 | 0.050 |
Why?
|
San Francisco | 1 | 2002 | 165 | 0.050 |
Why?
|
Quality Improvement | 1 | 2017 | 3845 | 0.050 |
Why?
|
Sinusitis | 1 | 2011 | 995 | 0.050 |
Why?
|
Genome, Bacterial | 2 | 2017 | 797 | 0.050 |
Why?
|
Program Development | 1 | 2007 | 1296 | 0.050 |
Why?
|
Penicillins | 1 | 2004 | 403 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2015 | 20131 | 0.040 |
Why?
|
Medicaid | 1 | 2013 | 2832 | 0.040 |
Why?
|
Monitoring, Physiologic | 1 | 2007 | 1794 | 0.040 |
Why?
|
Databases, Factual | 1 | 2015 | 8062 | 0.040 |
Why?
|
Demography | 1 | 2004 | 1640 | 0.040 |
Why?
|
Drug Prescriptions | 2 | 2008 | 1662 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2013 | 4303 | 0.040 |
Why?
|
Cost-Benefit Analysis | 3 | 2017 | 5529 | 0.040 |
Why?
|
Rectum | 2 | 2013 | 895 | 0.040 |
Why?
|
Medical Records | 2 | 2014 | 1409 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14644 | 0.030 |
Why?
|
Transformation, Bacterial | 1 | 2017 | 79 | 0.030 |
Why?
|
United States Government Agencies | 1 | 2016 | 26 | 0.030 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2000 | 618 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2006 | 1448 | 0.030 |
Why?
|
Gene Flow | 1 | 2016 | 79 | 0.030 |
Why?
|
Societies, Scientific | 2 | 2007 | 221 | 0.030 |
Why?
|
Subtilisins | 1 | 1995 | 80 | 0.030 |
Why?
|
Gloves, Protective | 1 | 2015 | 23 | 0.030 |
Why?
|
Models, Statistical | 1 | 2010 | 5089 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5889 | 0.030 |
Why?
|
Culture Media | 2 | 2007 | 889 | 0.030 |
Why?
|
Academies and Institutes | 1 | 2017 | 326 | 0.030 |
Why?
|
Time | 1 | 2016 | 549 | 0.030 |
Why?
|
Colony Count, Microbial | 1 | 2015 | 326 | 0.030 |
Why?
|
Suburethral Slings | 1 | 2015 | 69 | 0.030 |
Why?
|
Geography | 1 | 2016 | 651 | 0.030 |
Why?
|
Research Report | 1 | 2017 | 367 | 0.030 |
Why?
|
Current Procedural Terminology | 1 | 2015 | 100 | 0.030 |
Why?
|
Administration, Topical | 1 | 2016 | 703 | 0.030 |
Why?
|
Laminectomy | 1 | 2015 | 227 | 0.030 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 1995 | 309 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2017 | 791 | 0.030 |
Why?
|
DNA, Bacterial | 2 | 2010 | 1476 | 0.030 |
Why?
|
HIV Infections | 1 | 2000 | 17530 | 0.030 |
Why?
|
Clone Cells | 1 | 2017 | 1671 | 0.030 |
Why?
|
Confidentiality | 1 | 2017 | 607 | 0.030 |
Why?
|
Bacterial Load | 1 | 2013 | 156 | 0.030 |
Why?
|
Masks | 1 | 2015 | 209 | 0.030 |
Why?
|
Pituitary Gland | 1 | 1995 | 633 | 0.030 |
Why?
|
Advisory Committees | 2 | 2007 | 796 | 0.030 |
Why?
|
Cholecystectomy | 1 | 2015 | 409 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2017 | 2171 | 0.030 |
Why?
|
Health Records, Personal | 1 | 2013 | 126 | 0.020 |
Why?
|
Antidiarrheals | 1 | 2012 | 46 | 0.020 |
Why?
|
Foodborne Diseases | 1 | 2012 | 41 | 0.020 |
Why?
|
Cryptosporidium | 1 | 2012 | 43 | 0.020 |
Why?
|
Bacteriological Techniques | 1 | 2013 | 276 | 0.020 |
Why?
|
Enterotoxins | 1 | 2013 | 366 | 0.020 |
Why?
|
Reference Values | 2 | 2010 | 4911 | 0.020 |
Why?
|
Salmonella | 1 | 2012 | 122 | 0.020 |
Why?
|
Appendectomy | 1 | 2015 | 443 | 0.020 |
Why?
|
Diarrhea | 1 | 2018 | 1315 | 0.020 |
Why?
|
Comprehensive Health Care | 1 | 2012 | 123 | 0.020 |
Why?
|
Markov Chains | 1 | 2015 | 971 | 0.020 |
Why?
|
Health Priorities | 1 | 2014 | 382 | 0.020 |
Why?
|
Multilocus Sequence Typing | 1 | 2011 | 102 | 0.020 |
Why?
|
Bacterial Typing Techniques | 1 | 2011 | 263 | 0.020 |
Why?
|
Prosthesis Implantation | 1 | 2015 | 594 | 0.020 |
Why?
|
Recurrence | 1 | 2003 | 8506 | 0.020 |
Why?
|
Axilla | 1 | 2012 | 615 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2000 | 6304 | 0.020 |
Why?
|
Operon | 1 | 2010 | 371 | 0.020 |
Why?
|
Glucocorticoids | 1 | 1998 | 2132 | 0.020 |
Why?
|
Heart Failure | 1 | 2013 | 11838 | 0.020 |
Why?
|
Acetylglucosamine | 1 | 2010 | 190 | 0.020 |
Why?
|
Pacemaker, Artificial | 1 | 2015 | 829 | 0.020 |
Why?
|
Risk Adjustment | 1 | 2012 | 596 | 0.020 |
Why?
|
Sampling Studies | 1 | 2010 | 610 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1175 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6489 | 0.020 |
Why?
|
Reimbursement, Incentive | 1 | 2013 | 541 | 0.020 |
Why?
|
Bacterial Toxins | 1 | 2013 | 924 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2016 | 2353 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2687 | 0.020 |
Why?
|
International Cooperation | 1 | 2014 | 1432 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2000 | 3406 | 0.020 |
Why?
|
Illinois | 1 | 2007 | 120 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1510 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2169 | 0.020 |
Why?
|
Maryland | 1 | 2007 | 278 | 0.020 |
Why?
|
Research | 1 | 2014 | 1974 | 0.020 |
Why?
|
Survival Analysis | 1 | 1998 | 10087 | 0.020 |
Why?
|
Feces | 1 | 2012 | 1503 | 0.020 |
Why?
|
Antigens, Bacterial | 1 | 2010 | 1145 | 0.010 |
Why?
|
Societies, Medical | 2 | 2007 | 3950 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3104 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2010 | 65223 | 0.010 |
Why?
|
Decision Making | 1 | 2017 | 3955 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8725 | 0.010 |
Why?
|
Probability | 1 | 2008 | 2475 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8698 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8039 | 0.010 |
Why?
|
Disease Progression | 1 | 1998 | 13613 | 0.010 |
Why?
|
Drug Resistance | 1 | 2006 | 1590 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2011 | 26337 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2012 | 2513 | 0.010 |
Why?
|
Registries | 1 | 2015 | 8320 | 0.010 |
Why?
|
Managed Care Programs | 1 | 2004 | 934 | 0.010 |
Why?
|
Pituitary Gland, Anterior | 1 | 1998 | 142 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15398 | 0.010 |
Why?
|
Proprotein Convertase 2 | 1 | 1995 | 10 | 0.010 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 1995 | 66 | 0.010 |
Why?
|
Culture Techniques | 1 | 1995 | 515 | 0.010 |
Why?
|
Proprotein Convertases | 1 | 1995 | 95 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2010 | 14745 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9241 | 0.010 |
Why?
|
Molecular Weight | 1 | 1995 | 2162 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 1995 | 746 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1998 | 2087 | 0.010 |
Why?
|
Dexamethasone | 1 | 1998 | 1963 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1995 | 2477 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 1998 | 36542 | 0.010 |
Why?
|
Transfection | 1 | 1998 | 5742 | 0.010 |
Why?
|
Cattle | 1 | 1995 | 3801 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2008 | 15881 | 0.010 |
Why?
|
Animals | 3 | 2010 | 168730 | 0.000 |
Why?
|
Cell Membrane | 1 | 1995 | 3633 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1998 | 5127 | 0.000 |
Why?
|
Gene Expression | 1 | 1998 | 7581 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1998 | 7599 | 0.000 |
Why?
|
Cell Line | 1 | 1998 | 15540 | 0.000 |
Why?
|
Mice | 1 | 2010 | 81788 | 0.000 |
Why?
|
Rats | 1 | 1998 | 23707 | 0.000 |
Why?
|